Nutritional Immunology and Molecular Medicine Laboratory

Landos Biopharma to Present at the 38th Annual J.P. Morgan Healthcare Conference
Jan 09, 2020
Dr. Josep Bassaganya-Riera Speaks at the GBCB Seminar Series
Nov 22, 2019
Nutritional Immunology

NIMML leads a pioneering Nutritional Immunology program aimed at understanding how diet and nutritional factors influence the immune responses, thereby regulating health and disease outcomes.

Follow @NIMMLab on Twitter

Nuria Tubau Juni, NIMML PhD student, Awarded a Doctorate in Genetics, Bioinformatics and Computational Biology
Nov 18, 2019
Meghna Verma, NIMML PhD student, Awarded a Doctorate in TBMH
Nov 01, 2019
NIMML Alumna to speak at the GBCB Seminar series
Oct 14, 2019
Landos Biopharma Announces First Patient Dosed in Global Phase 2 Clinical Trial of BT-11 in Mild to Moderate Ulcerative Colitis
Aug 20, 2019
Computational Immunology

The Center for Modeling Immunity to Enteric Pathogens (MIEP) mission is to understand the underlying mechanisms of immune responses to enteric pathogens.
Landos Biopharma Completes $60 Million Series B Financing
Aug 13, 2019
Animal Models

The novel pig model presents a suitable avenue for studying effector and regulatory responses towards H. pylori described in humans.
Biotherapeutics, Inc. Announces Publication of Clinical Results from a Phase 1 study of Abscisic Acid for glycemic control in Healthy Human Subjects
Aug 03, 2019
NIMML Presents Computational Modeling for Biodefense at the 2019 Intelligent Systems for Molecular Biology Conference
Jul 29, 2019
NIMML Showcases its Advanced Computational Modeling Platform for Biodefense at the 2019 DTRA Life Science Technical Review
Jul 20, 2019
Decoding the Interface of Human Immunity and Metabolism
Jul 03, 2019
Advanced Computational Modeling of the Gut for Biodefense
Jun 11, 2019
Landos Biopharma Announces Publication of Results from First-in-Human Phase 1 Study of BT-11 in Healthy Volunteers
May 15, 2019
NIMML Helps Grow Virginia's Biotech Ecosystem
May 10, 2019